Hyaluronic acid-conjugated mesoporous silica nanoparticles: excellent colloidal dispersity in physiological fluids and targeting efficacy
- 10 February 2012
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry
- Vol. 22 (12) , 5615-5621
Abstract
Hyaluronic acid-conjugated mesoporous silica nanoparticles (MSNs-HA) have been synthesized via a facile amidation reaction. This novel strategy can efficiently solve the agglomeration problem of MSNs in physiological fluids. The cellular experiments showed that MSNs-HA is capable of selectively targeting specific cancer cells over-expressing the CD44 protein, leading to rapid and concentration-dependent uptake by the cancer cells through the receptor-mediated endocytosis mechanism. In contrast, no selective targeting of MSNs-HA can be found to the CD44 low-expressing cells, such as MCF-7 and L929 cells. The hydrophobic camptothecin (CPT) drug was encapsulated into MSNs-HA, which showed enhanced cytotoxicity to the Hela cells compared to both free CPT and CPT-loaded MSNs-HA in the presence of excess free HA.Keywords
This publication has 31 references indexed in Scilit:
- Use of Size and a Copolymer Design Feature To Improve the Biodistribution and the Enhanced Permeability and Retention Effect of Doxorubicin-Loaded Mesoporous Silica Nanoparticles in a Murine Xenograft Tumor ModelACS Nano, 2011
- Cancer-cell targeting and cell-specific delivery by mesoporous silica nanoparticlesJournal of Materials Chemistry, 2010
- Synthesis and Characterization of Biocompatible and Size-Tunable Multifunctional Porous Silica NanoparticlesChemistry of Materials, 2009
- Mediating Tumor Targeting Efficiency of Nanoparticles Through DesignNano Letters, 2009
- PEG-modified biopharmaceuticalsExpert Opinion on Drug Delivery, 2009
- Hyaluronic Acid−Paclitaxel Conjugate Micelles: Synthesis, Characterization, and Antitumor ActivityBioconjugate Chemistry, 2008
- Mesoporous Silica Nanoparticles as a Delivery System for Hydrophobic Anticancer DrugsSmall, 2007
- Formulation of functionalized PLGA–PEG nanoparticles for in vivo targeted drug deliveryBiomaterials, 2007
- PEG-modified gold nanorods with a stealth character for in vivo applicationsJournal of Controlled Release, 2006
- Hyaluronan: Preparation, Structure, Properties, and ApplicationsChemical Reviews, 1998